Published in:
Volume 3 / Year 2014 / Issue 3

Biosimilars collaboration at Amgen and Actavis

Page: 155-6

Abstract: Representatives from Amgen and Actavis have spoken to GaBI (Generics and Biosimilars Initiative) about biosimilars. Topics covered included the clinical development of biosimilars, the need for further education, how… Read More »

Go Back Print